Liquid-Based Cytology Detects Urinary Pathogens
|
By LabMedica International staff writers Posted on 29 Mar 2012 |
Liquid-based urine cytology (LB-URC) has been evaluated for cytological diagnosis and detection of Human papillomavirus (HPV), Mycoplasma, and Ureaplasma.
Liquid-based cytology (LBC) samples of urine sediment can be used to detect HPV and other microorganisms' DNA, while evaluating the cytological findings of urine sediment tests based on Papanicolaou staining and performing in situ hybridization (ISH).
At the Kanazawa University Hospital (Japan) 141 male patients with urethritis (urethritis group) and 154 male patients without urethritis (controls) were enrolled in a study between April 2009 and April 2010. Each patient provided a midstream urine specimen. All patients with urethritis were tested for the presence of Neisseria gonorrhoeae and Chlamydia trachomatis in urethral swabs. The HPV status for each patient was determined. Mycoplasma, Ureaplasma, and HPV genomes were determined by polymerase chain reaction (PCR)-based methods. Papanicolaou tests were performed for cytological evaluation and localization of HPV DNA in urothelial cells was examined by ISH.
HPV DNA was detected in 29 (21.0%) urethritis cases and in 5 (3.3%) controls. HPV genotyping was performed using HPV GenoArray test kits (HybriBio Limited; Hong Kong SAR, China) and HPV type 16 (HPV 16) was most commonly found in urethritis patients. Morphological changes suggestive of HPV infection were seen in 20.7% of the HPV-positive samples, and ISH using the Dako GenoPoint System (Dako; Carpinteria, CA, USA) demonstrated the presence of HPV DNA in both squamous and urothelial cells in HPV-positive samples.
Mycoplasma genitalium, M. hominis, Ureaplasma parvum, and U. urealyticum were detected using a multiplex PCR assay in 14.5%, 10.9%, 6.5%, and 12.3% of urethritis patients, respectively. The authors concluded that that LB-URC is a promising method for molecular analysis of microorganisms in the urinary tract and that HPV infection occurs in urothelial cells, especially in gonococcal urethritis. The study was published in the February 2012 issue of the Journal of Clinical Microbiology.
Related Links:
Kanazawa University Hospital
HybriBio Limited
Dako
Liquid-based cytology (LBC) samples of urine sediment can be used to detect HPV and other microorganisms' DNA, while evaluating the cytological findings of urine sediment tests based on Papanicolaou staining and performing in situ hybridization (ISH).
At the Kanazawa University Hospital (Japan) 141 male patients with urethritis (urethritis group) and 154 male patients without urethritis (controls) were enrolled in a study between April 2009 and April 2010. Each patient provided a midstream urine specimen. All patients with urethritis were tested for the presence of Neisseria gonorrhoeae and Chlamydia trachomatis in urethral swabs. The HPV status for each patient was determined. Mycoplasma, Ureaplasma, and HPV genomes were determined by polymerase chain reaction (PCR)-based methods. Papanicolaou tests were performed for cytological evaluation and localization of HPV DNA in urothelial cells was examined by ISH.
HPV DNA was detected in 29 (21.0%) urethritis cases and in 5 (3.3%) controls. HPV genotyping was performed using HPV GenoArray test kits (HybriBio Limited; Hong Kong SAR, China) and HPV type 16 (HPV 16) was most commonly found in urethritis patients. Morphological changes suggestive of HPV infection were seen in 20.7% of the HPV-positive samples, and ISH using the Dako GenoPoint System (Dako; Carpinteria, CA, USA) demonstrated the presence of HPV DNA in both squamous and urothelial cells in HPV-positive samples.
Mycoplasma genitalium, M. hominis, Ureaplasma parvum, and U. urealyticum were detected using a multiplex PCR assay in 14.5%, 10.9%, 6.5%, and 12.3% of urethritis patients, respectively. The authors concluded that that LB-URC is a promising method for molecular analysis of microorganisms in the urinary tract and that HPV infection occurs in urothelial cells, especially in gonococcal urethritis. The study was published in the February 2012 issue of the Journal of Clinical Microbiology.
Related Links:
Kanazawa University Hospital
HybriBio Limited
Dako
Latest Pathology News
- 3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
- Blood-Based Method Tracks Gene Activity in the Living Brain
- FDA Approval Expands Automated PD-L1 Testing Across Solid Tumors
- AI-Powered Atlas Maps Immune Structures Linked to Cancer Outcomes
- AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy
- Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
- AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
- FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
- New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
- AI System Analyzes Routine Pathology Slides to Predict Cancer Outcomes
- New Tissue Mapping Approach Identifies High-Risk Form of Diabetic Kidney Disease
- Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment
- Interpretable AI Reveals Hidden Cellular Features from Microscopy Images
- Tumor Immune Structure Predicts Response to Immunotherapy in Melanoma
- Plug-and-Play AI Pathology System Classifies Multiple Cancers from Few Slides
- AI-Based Assays Support Risk Stratification in Prostate and Breast Cancer
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








